Related Experiment Video
Updated: May 16, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Therapeutic challenges in acquired factor VIII deficiency
1Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff University, Cardiff, United Kingdom. peter.collins@wales.nhs.uk
Hematology. American Society of Hematology. Education Program
|December 13, 2012
Summary
Managing acquired hemophilia A requires expert care to control bleeds and eradicate inhibitors. Prompt diagnosis and appropriate hemostatic and immunosuppressive therapies are crucial for effective treatment and preventing relapse.
Area of Science:
- Hematology
- Immunology
Background:
- Acquired hemophilia A (AHA) presents unique management challenges.
- It requires specialized care, often in collaboration with hemophilia centers.
Purpose of the Study:
- To outline current best practices for managing acquired hemophilia A.
- To detail effective hemostatic and immunosuppressive strategies.
Main Methods:
- Review of current treatment guidelines and clinical data for AHA management.
- Focus on diagnostic promptness, hemostatic agent selection, and immunosuppressive regimens.
Main Results:
- First-line hemostatic treatment involves bypassing agents like recombinant activated factor VII or FEIBA, despite thrombotic risks.
- Immunosuppression, particularly steroids with cyclophosphamide, is recommended upon diagnosis.
- Rituximab has not shown superior outcomes compared to other regimens.
Conclusions:
- Effective AHA management necessitates prompt diagnosis, early hemostatic intervention, and timely immunosuppression.
- Relapse is common post-immunosuppression, requiring regular follow-up for early detection and treatment.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...